乌比基素独立途径调节了瘤进展中的RIT1-MAPK途径
Hui Chen1,2,3, Qiujing Guan2, Cheng Yang4
1Department of Trauma-Emergency & Critical Care Medicine, Shanghai Fifth People's Hospital, Fudan University, Shanghai, China.
Cell death & disease
|October 24, 2025
概括
这项研究确定了REGγ作为冠状动脉瘤的有前途的治疗点. 调节后的 REGγ 通过降低 RIT1 来促进心脏瘤的进展,提供了一种新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 脊髓瘤是一种罕见的,缓慢生长的骨癌,起源于脊髓残留物,由于其靠近重要结构,经常在当地复发.
- 蛋白质酶体系统调节细胞内蛋白质降解,蛋白质酶体激活剂REGγ与各种癌症有关,但其在瘤中的作用尚不清楚.
- 像RIT1这样的ras GTPases参与癌症进展,呈现出潜在的治疗途径.
研究的目的:
- 调查REGγ在心脏瘤发病过程中的作用,并评估其作为潜在的治疗点.
- 为了探索REGγ表达和胆瘤患者的临床结果之间的关系.
- 阐明REGγ影响胆瘤进展的分子机制.
主要方法:
- 分析心肌瘤组织中的REGγ表达和与临床数据的相关性.
- 在体外实验中评估REGγ对瘤细胞增殖,迁移和亡的影响.
- 研究涉及REGγ,RIT1和MAPK信号通路的调控通路.
- 在患者衍生器官模型中验证.
主要成果:
- 在心脏瘤中,REGγ被上调,并与不良的临床结果相关.
- REGγ 过度表达促进了冠状瘤细胞的增殖和迁移,同时抑制了细胞亡,并影响了骨质细胞分化.
- REGγ通过无素和ATP独立降解RIT1,调节RIT1-MAPK通路来驱动胆瘤的进展.
- 在REGγ-knockdown模型和有机体中准RIT1改善了疾病的进展.
结论:
- REGγ是瘤进展的关键驱动因素,也是潜在的治疗点.
- 针对REGγ-RIT1轴为心瘤治疗提供了一个新的治疗策略.
- 对REGγ抑制的进一步研究可能会使瘤患者的临床结果得到改善.
相关概念视频
03:03mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
01:22PI3K/mTOR/AKT Signaling Pathway
5.2K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.2K
01:07MAPK Signaling Cascades
7.8K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.8K
01:31The Intrinsic Apoptotic Pathway
8.1K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.1K
02:23Abnormal Proliferation
5.0K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
01:19Interactions Between Signaling Pathways
7.1K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.1K